# Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

> **NCT07298408** · PHASE1,PHASE2 · RECRUITING · sponsor: **Florida A&M University** · enrollment: 20 (estimated)

## Conditions studied

- Diabetic Peripheral Neuropathic Pain (DPN)
- Diabetic Neuropathies

## Interventions

- **DRUG:** Cannabidiol (CBD) oral solution
- **DRUG:** Full-Spectrum CBD hemp extract oral solution
- **DRUG:** Placebo in MCT oil oral solution

## Key facts

- **NCT ID:** NCT07298408
- **Lead sponsor:** Florida A&M University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-02
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07298408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07298408, "Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07298408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*